Full record

Missmarkets

Palantir (PLTR) will trade above $50 per share by the end of 2021.

A scored prediction by Tom Nash, made on .

VideoQuote from the original sourcemarkets

Scored prediction

Missmarkets

talent year will break through the 50 mark by the end of this year

Palantir (PLTR) will trade above $50 per share by the end of 2021.

Made on
2021-05-02
Outcome
Miss
Importance
3 / 5
Effect on score
-1.33

What counted as right

Status
resolved
Settled on
2021-12-31

PLTR share price reaches or exceeds $50 at any point on or before 2021-12-31.

Criterion: PLTR reaches/exceeds $50 at any point on or before 2021-12-31. Its 2021 peak (~$39-45, late Jan 2021) never reached $50; the exact peak figure does not affect resolution since both candidate figures are well below $50. Deadline passed 2021-12-31.

Sources

  • What's Next for Palantir?

    YouTube ·

    Source

Evidence of what happened

  • PLTR's 2021 high was reached in late January 2021 (roughly $39-45 range depending on intraday vs close source); it declined for the rest of the year and never approached $50 at any point in 2021.

    Evidence

  • Forbes: 'Palantir Stock Had A Tough 2021' — confirms the stock fell through the year and did not set new highs above its early-2021 peak (well under $50).

    Evidence

Corrections

No public corrections.

Effect on the score

-1.33
How sure they sounded
85%
Outcome
Miss
Importance
3 / 5

This page shows the scored prediction as published; the site doesn't recompute or adjust the score.

Where this came from

Palantir (PLTR) will trade above $50 per share by the end o…
Methodology version
v1.0.0
Last computed
August 2, 2026
Made on
2021-05-02

How this profile was built

  1. Scored by independent judges

  2. Predictions gathered and sourced

  3. Independently verified against sources

Every public score traces back to sourced prediction records.

Avow is an independent project. The pundits scored here are not affiliated with Avow and do not endorse it. Names and likenesses are used for identification and commentary.

Evidence firstMethodologyPrivacy